Tassone Felicia, Di Ciano Patricia, Liu Yuxin, Rueda Sergio
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Front Psychiatry. 2023 Feb 16;14:1111330. doi: 10.3389/fpsyt.2023.1111330. eCollection 2023.
Cannabis was legalized in Canada in October 2018, regulating the production, distribution, sale, and possession of dried cannabis and cannabis oils. Additional products were legalized 1 year later, including edibles, concentrates, and topicals, with new lines of commercial products coming to market. Ontario is the most populous province in Canada and has the largest cannabis market with the highest number of in-person retail stores and the most cannabis products available online. This study aims to create a profile of products available to consumers three years after legalization by summarizing types of products, THC and CBD potency, plant type, and prices of product sub-categories.
We extracted data from the website of the Ontario Cannabis Store (OCS)-the public agency overseeing the only online store and sole wholesaler to all authorized in-person stores-in the first quarter of 2022 (January 19-March 23). We used descriptive analyses to summarize the data. A total of 1,771 available products were mapped by route of administration into inhalation (smoking, vaping, and concentrates), ingestible (edibles, beverages, oils, and capsules) and topical.
Most inhalation products included ≥20%/g THC (dried flower: 94%; cartridges: 96%; resin: 100%) while ingestible products had similar proportions of THC and CBD content. Indica-dominant products tend to be more prominent in inhalation products while sativa-dominant products tend to be more prominent in ingestible products. The average sale price of cannabis was 9.30 $/g for dried flower, 5.79 $/0.1g for cartridges, 54.82 $/g for resin, 3.21 $/unit for soft chews, 1.37 $/ml for drops, 1.52 $/unit for capsules, and 39.94 $/product for topicals.
In summary, a wide variety of cannabis products were available to Ontarians for different routes of administration and provides numerous indica-dominant, sativa-dominant, and hybrid/blend options. The current market for inhalation products however is geared towards the commercialization of high-THC products.
2018年10月，加拿大将大麻合法化，对干大麻和大麻油的生产、分销、销售及持有进行规范。一年后，其他产品也合法化，包括可食用产品、浓缩物和外用药膏，新的商业产品线进入市场。安大略省是加拿大人口最多的省份，拥有最大的大麻市场，实体零售店数量最多，网上可购买的大麻产品也最多。本研究旨在通过总结产品类型、四氢大麻酚（THC）和大麻二酚（CBD）含量、植物类型以及产品子类别的价格，描绘大麻合法化三年后消费者可获得的产品概况。
我们于2022年第一季度（1月19日至3月23日）从安大略大麻商店（OCS）的网站提取数据，该机构是监管唯一在线商店及所有授权实体商店唯一批发商的公共机构。我们使用描述性分析来总结数据。总共1771种在售产品按给药途径分为吸入类（吸烟、雾化和浓缩物）、可食用类（可食用产品、饮料、油和胶囊）和外用类。
大多数吸入类产品的THC含量≥20%/克（干花：94%；烟弹：96%；树脂：100%），而可食用产品中THC和CBD含量比例相近。以印度大麻为主的产品在吸入类产品中往往更为突出，而以大麻为主的产品在可食用产品中往往更为突出。大麻的平均售价为：干花9.30美元/克，烟弹5.79美元/0.1克，树脂54.82美元/克，软糖3.21美元/单位，滴剂1.37美元/毫升，胶囊1.52美元/单位，外用药膏39.94美元/产品。
总之，安大略省居民可获得多种不同给药途径的大麻产品，提供了众多以印度大麻为主、以大麻为主以及杂交/混合的选择。然而，目前的吸入类产品市场倾向于高THC产品的商业化。
